IOVANCE BIOTHERAPEUTICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-227.9M | $-265.5M | $37.6M | $69.8M |
| FY2022 | $-292.8M | $-313.2M | $20.4M | $84.0M |
| FY2023 | $-361.8M | $-384.1M | $22.3M | $62.6M |
| FY2024 | $-353.0M | $-364.0M | $11.1M | $109.6M |
| FY2025 | $-302.4M | $-336.2M | $33.8M | $61.6M |